FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000753886> ?p ?o ?g. }

• W2000753886 endingPage "1446" @default.
• W2000753886 startingPage "1446" @default.
• W2000753886 abstract "Medication persistence is an important factor for treatment effect in patients with glaucoma. Evaluating risk factors for refill discontinuation might be helpful for improving persistence and preventing blindness in patients with glaucoma.To estimate the persistence rate with topical glaucoma medication 2 years after diagnosis and evaluate risk factors for nonpersistence among patients in Taiwan with open-angle glaucoma and ocular hypertension.A retrospective population-based study using claims data from the National Health Insurance Research Database. One million patients were randomly selected from the registered beneficiaries of the National Health Insurance Research Database in 2000. All patients with newly diagnosed open-angle glaucoma and ocular hypertension were included and followed up until December 31, 2008. Patients were included in the analysis only if they had follow-up data for more than 2 years after diagnosis.Nonpersistence was defined as the patient not refilling any topical glaucoma medication for more than 90 days. Patient characteristics, prescription-related clinical factors, and physician and hospital characteristics were identified and considered in the analysis. The rate of persistence was estimated and risk factors for nonpersistence were investigated using Cox proportional regression models.A total of 3134 patients were identified and observed in the study. After a 2-year follow-up, 759 patients (24.2%) persisted with their glaucoma medications. Multivariate analysis showed that patients' living or working areas (P < .001), number of glaucoma medications (P < .001), prescription of pilocarpine hydrochloride (adjusted ratio of persistence = 0.72; 95% CI, 0.59-0.88) or prostaglandin analogs (adjusted ratio of persistence = 2.04; 95% CI, 1.82-2.33), the year in which glaucoma diagnosis was made (adjusted ratios of persistence for patients whose condition was diagnosed after 2004 = 1.18; 95% CI, 1.09-1.27), sex of the main physicians (adjusted ratios of persistence for male ophthalmologists = 0.82; 95% CI, 0.74-0.90), treatment in hospitals (P < .001), and continuity of care index (P < .001) were associated with patients' persistence with glaucoma medications.The rate of persistence for glaucoma medications is low in Taiwan, although health care costs, including the cost of medication, are mostly covered by the nationwide health insurance system. This study suggests that factors other than cost, such as physician-patient relationship and patient education, may play an important role in the persistence of topical glaucoma medication." @default.
• W2000753886 created "2016-06-24" @default.
• W2000753886 creator A5001970513 @default.
• W2000753886 creator A5009029907 @default.
• W2000753886 creator A5018324462 @default.
• W2000753886 creator A5029792396 @default.
• W2000753886 creator A5089691850 @default.
• W2000753886 date "2014-12-01" @default.
• W2000753886 modified "2023-10-06" @default.
• W2000753886 title "Persistence of Topical Glaucoma Medication" @default.
• W2000753886 cites W10727480 @default.
• W2000753886 cites W110800803 @default.
• W2000753886 cites W1546824566 @default.
• W2000753886 cites W1965539274 @default.
• W2000753886 cites W1973722314 @default.
• W2000753886 cites W1981831528 @default.
• W2000753886 cites W1984786076 @default.
• W2000753886 cites W1988854825 @default.
• W2000753886 cites W1995463634 @default.
• W2000753886 cites W2002045610 @default.
• W2000753886 cites W2006971510 @default.
• W2000753886 cites W2013333151 @default.
• W2000753886 cites W2015733557 @default.
• W2000753886 cites W2016814912 @default.
• W2000753886 cites W2023077048 @default.
• W2000753886 cites W2023104235 @default.
• W2000753886 cites W2023247429 @default.
• W2000753886 cites W2026975672 @default.
• W2000753886 cites W2042265219 @default.
• W2000753886 cites W2046901203 @default.
• W2000753886 cites W2066361855 @default.
• W2000753886 cites W2068598411 @default.
• W2000753886 cites W2069610404 @default.
• W2000753886 cites W2072156581 @default.
• W2000753886 cites W2078889609 @default.
• W2000753886 cites W2079924717 @default.
• W2000753886 cites W2083270448 @default.
• W2000753886 cites W2091063199 @default.
• W2000753886 cites W2091441457 @default.
• W2000753886 cites W2108828807 @default.
• W2000753886 cites W2114542753 @default.
• W2000753886 cites W2126394207 @default.
• W2000753886 cites W2132045077 @default.
• W2000753886 cites W2140594570 @default.
• W2000753886 cites W2160276055 @default.
• W2000753886 cites W2187497799 @default.
• W2000753886 cites W2229861203 @default.
• W2000753886 cites W77126782 @default.
• W2000753886 doi "https://doi.org/10.1001/jamaophthalmol.2014.3333" @default.
• W2000753886 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25211300" @default.
• W2000753886 hasPublicationYear "2014" @default.
• W2000753886 type Work @default.
• W2000753886 sameAs 2000753886 @default.
• W2000753886 citedByCount "41" @default.
• W2000753886 countsByYear W20007538862015 @default.
• W2000753886 countsByYear W20007538862016 @default.
• W2000753886 countsByYear W20007538862017 @default.
• W2000753886 countsByYear W20007538862018 @default.
• W2000753886 countsByYear W20007538862019 @default.
• W2000753886 countsByYear W20007538862020 @default.
• W2000753886 countsByYear W20007538862021 @default.
• W2000753886 countsByYear W20007538862022 @default.
• W2000753886 countsByYear W20007538862023 @default.
• W2000753886 crossrefType "journal-article" @default.
• W2000753886 hasAuthorship W2000753886A5001970513 @default.
• W2000753886 hasAuthorship W2000753886A5009029907 @default.
• W2000753886 hasAuthorship W2000753886A5018324462 @default.
• W2000753886 hasAuthorship W2000753886A5029792396 @default.
• W2000753886 hasAuthorship W2000753886A5089691850 @default.
• W2000753886 hasBestOaLocation W20007538861 @default.
• W2000753886 hasConcept C118487528 @default.
• W2000753886 hasConcept C126322002 @default.
• W2000753886 hasConcept C127413603 @default.
• W2000753886 hasConcept C167135981 @default.
• W2000753886 hasConcept C187212893 @default.
• W2000753886 hasConcept C187320778 @default.
• W2000753886 hasConcept C2426938 @default.
• W2000753886 hasConcept C2776508836 @default.
• W2000753886 hasConcept C2776521421 @default.
• W2000753886 hasConcept C2778527774 @default.
• W2000753886 hasConcept C2778715236 @default.
• W2000753886 hasConcept C2781009140 @default.
• W2000753886 hasConcept C2908647359 @default.
• W2000753886 hasConcept C50382708 @default.
• W2000753886 hasConcept C71924100 @default.
• W2000753886 hasConcept C98274493 @default.
• W2000753886 hasConcept C99454951 @default.
• W2000753886 hasConceptScore W2000753886C118487528 @default.
• W2000753886 hasConceptScore W2000753886C126322002 @default.
• W2000753886 hasConceptScore W2000753886C127413603 @default.
• W2000753886 hasConceptScore W2000753886C167135981 @default.
• W2000753886 hasConceptScore W2000753886C187212893 @default.
• W2000753886 hasConceptScore W2000753886C187320778 @default.
• W2000753886 hasConceptScore W2000753886C2426938 @default.
• W2000753886 hasConceptScore W2000753886C2776508836 @default.
• W2000753886 hasConceptScore W2000753886C2776521421 @default.
• W2000753886 hasConceptScore W2000753886C2778527774 @default.
• W2000753886 hasConceptScore W2000753886C2778715236 @default.

• next